not vested
Cordlife Group, a cord blood and tissue banking service provider, said its second-quarter net profit jumped 2.9 times to S$5.6 million for the three months ended December, compared to S$1.9 million a year earlier.
The increase in revenue was boosted by more client deliveries and a one-time disposal gain of its 10 percent interest in China Stem Cells (South) Company Limited.
Source: Reuters